In the drug‐target MR analyses, we attempted to evaluate effects of 15 lipid‐modifying targets on pancreatitis, namely, HMGCR, NPC1L1, PCSK9, APOB, LDLR, ABCG5, ABCG8, ACLY, ANGPTL3, MTTP, PPARA, PPARD, PPARG, APOC3, and LPL. This evidence concerns the gene LPL and pancreatitis.